TRIZ Developers Summit


Section "TRIZ in Business"

Abstracts of presentations

Anton Kulakov. TRIZ competency matrix as a crucial component of the system for widespread TRIZ application at industrial facilities

With the widespread introduction of TRIZ to industrial facilities, the authors discovered a number of systemic contradictions that slow down TRIZ implementation and lower its quality. The foundation for resolving these contradictions is the TRIZ Competency Matrix that the authors created based on the Icarus and Daedalus certification system. The authors of the report will dissect the core of these contradictions, the structure of the Competency Matrix and its relationship with TRIZ project activities, and the development of employees' TRIZ tool-use skills so that  a tangible economic impact from TRIZ activities can be achieved in the aluminium industry. Practical developments in the formats and ways of developing TRIZ competencies among employees involved in operational activities will be revealed.


Mikhail Rubin, Anton Kulakov, Aleksandr Trantin. Motivation management system for implementing TRIZ projects at production facilities

For any project implementation-based system, managing the team's motivation is a charged issue. The very current model of approach to improvement projects is the root cause of the challenges encountered when implementing TRIZ projects at non-ferrous metal-making industrial facilities. The report will analyse the key characteristics of this project-oriented approach, highlight the issue of establishing a motivation management system through non-financial motivation development aspects and analyse cases that show the efficiency of the author's proposed solutions for developing a project team motivation management system.


Alexander Tokarev. Problems of implementing TRIZ in industry and their solving methods

The use of TRIZ at industrial enterprises allows solving many problems related to improving business performance. In particular, resource saving, quality improvement, stabilization of process and product parameters, as well as organizational and business objectives. However, the experience of implementing TRIZ at mass production enterprises shows that there are some difficulties.

Over the course of four years of work, we have accumulated extensive experience working with teams of specialists solving production problems using TRIZ. Let's look at the most common problems, as well as methods that can overcome them.


A. Kozhemyako. Achieving an Organisation's Strategic Objectives Using TIPS Tools

1. Why do strategy sessions often fail to bring expected results?
2. The concept of an organisation's activities.
3. Difficulties associated with decomposing an organisation's activities.
4. Application of the Impact Mapping (IM) analytical tool with a sweep from strategic goals to specific objectives.
Examples from real cases implemented by BATRIZ.
5. Problematisation based on the results of IM application and compiling a technical inconsistency system.
6. Dealing with multiple technical inconsistencies in business systems – as an overview, without going into detail.
7. Synthesising a solution and developing a transformation programme.


A. Kulakov. KulakovResults of Roadmap Module Development in Compinno-TRIZ and Its Practical Use at
Aluminium Industry Production Facilities

Efficient arrangement of TIPS project implementation logic requires from a project manager thorough understanding
of not only TIPS tools themselves, but also of interrelationships between them. Improving the competences of the
project manager to such understanding is, first of all, time-consuming, which is a limiting factor in mass
implementation of TIPS at industrial production facilities. Therefore, creation of an automated and intuitive
mechanism for building TIPS project roadmaps is the key to eliminating such limiting factors. In the report, the author
will describe the continuation of the work on automation of the roadmapping process – a forecast of the development
of TIPS project planning methods, the results of using the Roadmaps Module and of evaluating its efficiency in TIPS
project planning.


Ilya Balyko. Compliance of certain manager psychological types with various technical system development stages under the S-shaped Development Nature system law

One of the main laws governing the development of technical systems is the S-shaped Development Nature law. In this publication, we propose to consider the hypothesis that there is a correspondence between specific psychological types (sociotypes) from the Socionics theory based on Carl Jung's ideas and the stages of a technical system's life cycle as defined by the S-shaped Development Nature law. We hypothesise that, due to its internal dialectics, each stage of the system's development can be matched to a specific psychological type (sociotype) of a person (people who are a part of the leadership team at this stage) whose sociotype's specifics are the best match to that stage's key elements. Thus, the system's potential at each stage of progress along the S-shaped development curve can be utilised to the fullest extent (brought as close as possible to the ideal state).


B. Gelezko. Experience of TIPS application in marketing specialist training

The report summarises the author's experience of using TIPS methodology in studying by undergraduate, master and
postgraduate students of technologies and systems for supporting marketing decisions.


Anastasia Titorenko, L. Dautova, S. Domaratsky. Specifics of TRIZ use in sales management

Sales department heads often face quick, non-linear tasks, and human resources serve as a fundamental means of solving them. Aspects of using TRIZ at sales units of an IT company are considered.


Dr. Boris Farber, Dr. Artur Martynov. Dynamization of medical drugs - a revolutionary approach in pharmacy

TRIZ Biopharma International, LLC, Noigel, LLC, Farber’s Center, Inc.

The authors have introduced a new revolutionary approach Dynamization of medical drugs in pharmacy. Dynamic classes of drugs with variable structures have the ability to adapt to the specific organism of any patient and the target organism such as microorganisms, viruses, or cancer cells. The report provides theoretical substantiation, modeling, and practical confirmation for this previously unknown approach.
Our research in pharma, analysis of the Technical Systems Law trend, and examination of the industry's current state have led us to develop a pioneering approach to drug dynamization. Many companies in the industry are dedicating a larger portion of their net revenues to R&D, surpassing even knowledge-intensive fields like semiconductors and software. Despite an increase in the number of approved new drugs and funding for their development, the effectiveness of some drugs hasn't improved in proportion to the costs. For instance, developing new antibiotics and increasing their dosage doesn't always produce the desired outcome.
Improper use of antibiotics can lead to selective selection, which increases the resistance of bacteria to antibiotics. Additionally, antibiotics are not effective against bacteria with multidrug resistance as they cannot keep up with the bacteria's mutation. After years of research and development, we have created a new class of dynamic drugs that have a variable structure to adapt to the organism they are targeting, whether it is a human body, pathogen, or virus. With these drugs, we no longer need to give large amounts of medication with high dosages or worry about the antibiotic not being effective initially, or the bacteria becoming resistant over time. Dynamic antibiotics prevent bacteria from adapting and becoming resistant.
We have developed a class of drugs known as "dynamic drugs." One of these drugs is a dynamic anticancer agent that is based on RNA. When tested on animals with inoculated tumors, this drug protected them from death, while the control groups experienced fatalities by the end of the experiment. Another dynamic drug has been created to combat rapidly changing and mutating viral infections. This drug is called dynamic insulin, and it can be taken orally in tablet or solution form. Unlike injectable forms of insulin, dynamic insulin doesn't typically cause hypoglycemia (a drop in blood glucose levels).
There are new dynamic peptide drugs such as alpha-interferon, gamma-interferon, and interleukin-2 that have a wider range of effects on tumors compared to traditional drugs. Other dynamic drugs are also being developed using low molecular weight compounds. This approach involves creating a new class of dynamic drugs with a variable structure that can adapt to the patient's needs. The authors have obtained patents for these dynamic drugs in various countries around the world to protect their development.
Keywords: TRIZ, S-form curve, Laws of Development of Technical Systems, dynamic drugs, mutation, mathematical modeling, pharmacology, synergy.